Tax Problems and Improvements in the Korean Pharmaceutical Industry
0
조회
0
다운로드
0
인용
0
참고문헌
키워드
초록
The Korean pharmaceutical industry faces significant tax-related challenges despite its substantial investment in research and development (R&D). Key issues include limited R&D tax credits, double taxation on international transactions, and a complex tax system that hinders both innovation and global competitiveness. Expanding R&D tax credits to encompass all stages of drug development from early research to clinical trials and commercialization is essential to encourage greater investment in innovation. Additionally, improving the taxation of royalties and technology transfer income will help alleviate the burden of double taxation. Strengthening international tax treaties and streamlining the tax compliance process for multinational operations will also reduce administrative barriers for global collaboration. Lowering corporate tax rates, especially for companies with heavy R&D investment, and introducing specific tax benefits for new drug commercialization and patent licensing will further enhance reinvestment in innovation. Simplifying the value-added tax (VAT) refund process, particularly for smaller firms, will improve cash flow and financial flexibility. These tax reforms are critical to fostering a more competitive and innovation-driven environment for the Korean pharmaceutical sector, ensuring sustainable growth and bolstering its position in the global market.
Abstract
The Korean pharmaceutical industry faces significant tax-related challenges despite its substantial investment in research and development (R&D). Key issues include limited R&D tax credits, double taxation on international transactions, and a complex tax system that hinders both innovation and global competitiveness. Expanding R&D tax credits to encompass all stages of drug development from early research to clinical trials and commercialization is essential to encourage greater investment in innovation. Additionally, improving the taxation of royalties and technology transfer income will help alleviate the burden of double taxation. Strengthening international tax treaties and streamlining the tax compliance process for multinational operations will also reduce administrative barriers for global collaboration. Lowering corporate tax rates, especially for companies with heavy R&D investment, and introducing specific tax benefits for new drug commercialization and patent licensing will further enhance reinvestment in innovation. Simplifying the value-added tax (VAT) refund process, particularly for smaller firms, will improve cash flow and financial flexibility. These tax reforms are critical to fostering a more competitive and innovation-driven environment for the Korean pharmaceutical sector, ensuring sustainable growth and bolstering its position in the global market.
참고문헌 (28)
- Bradley, S., "Cross-country evidence on the preliminary effects of patent box regimes on patent activity and ownership", National Tax Journal, 68(4), pp.1047~1072 (2015)
- Chyz, J. A., "Personally tax aggressive executives and corporate tax sheltering", Journal of Accounting and Economics, 56(2-3), pp.311~328 (2013)
- Desai, M. A., "The demand for tax haven operations", Journal of Public Economics, 90(3), pp.513~531 (2006)
- Devereux, M. P., "Evaluating tax policy for location decisions", International Tax and Public Finance, 10(2), pp.107~126 (2003)
- Dharmapala, D., "What do we know about base erosion and profit shifting? A review of the empirical literature", Fiscal Studies, 35(4), pp.421~448 (2014)
- Faccio, M., "Taxes and capital structure", Journal of Financial and Quantitative Analysis, 50(3), pp.277~300 (2015)
- Graetz, M. J., "100 million unnecessary returns: A fresh start for the US tax system", Yale Law Journal, pp.1125~1176 (2008)
- Griffith, R., "Ownership of intellectual property and corporate taxation", Journal of Public Economics, 112, pp.12~23 (2014)
- Hanlon, M., "A review of tax research", Journal of Accounting and Economics, 50(2-3), pp.127~178 (2010)
- Hines Jr. J. R., "Treasure islands", Journal of Economic Perspectives, 24(4), pp.103~126 (2010)
- Jang, W. Y., "Analysis of Double Taxation Issues in International Technology Transfers in the Korean Pharmaceutical Sector", Korean Taxation Research Journal, 29(1), pp.91~113 (2021)
- Kim, Y. H., "The Effect of R&D Tax Credits on Innovation in Korean Pharmaceutical Companies", Korean Journal of Taxation, 40(2), pp.45~67 (2023)
- Klassen, K. J., "Transfer pricing : Strategies, practices, and tax minimization", Contemporary Accounting Research, 34(1), pp.455~493 (2017)
- Klassen, K. J., "Transfer pricing : Strategies, practices, and tax minimization", Contemporary Accounting Research, 34(1), pp.455~493 (2017)
- Korea Customs Service Export Data Report, , ~ (2023)
- Korea Pharmaceutical and Bio-Pharma Manufacturers Association Report, , ~ (2023)
- Korean Statistical Information Service Report, , ~ (2023)
- Ministry of Health and Welfare Annual Report, , ~ (2023)
- Mintz, J., "Income shifting, investment, and tax competition : Theory and evidence from provincial taxation in Canada", Journal of Public Economics, 88(6), pp.1149~1168 (2004)
- Mintz, J., "Income shifting, investment, and tax competition : Theory and evidence from provincial taxation in Canada", Journal of Public Economics, 88(6), pp.1149~1168 (2004)
- Morck, R., "Dividend taxation and corporate governance", Journal of Economic Perspectives, 19(3), pp.163~180 (2005)
- National Tax Service Corporate Tax Report, , ~ (2023)
- OECD R&D Investment Efficiency Report, , ~ (2022)
- Park, S. M., "Comparative Study on Corporate Tax Incentives for R&D in the Korean and Global Pharmaceutical Industries", Journal of Korean Economic Policy, 36(4), pp.125~148 (2022)
- Park, S. M., "Comparative Study on Corporate Tax Incentives for R&D in the Korean and Global Pharmaceutical Industries", Journal of Korean Economic Policy, 36(4), pp.125~148 (2022)
- Sorensen, P. B., "The theory of optimal taxation : What is the policy relevance", International Tax and Public Finance, 14(6), pp.383~406 (2007)
- Sorensen, P. B., "The theory of optimal taxation : What is the policy relevance", International Tax and Public Finance, 14(6), pp.383~406 (2007)
- Wilson, J. D., "Theories of tax competition", National Tax Journal, 52(2), pp.269~304 (1999)